{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:06:36Z","timestamp":1793318796419,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010344","name":"Scan|Design Foundation by Inger and Jens Bruun","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100010344","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016506","name":"Alcohol and Drug Abuse Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016506","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41386-019-0585-3","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T09:02:43Z","timestamp":1575709363000},"page":"1105-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain"],"prefix":"10.1038","volume":"45","author":[{"given":"Antony D.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J. Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenden A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-5097","authenticated-orcid":false,"given":"Zeena M. G.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,7]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","volume":"11","author":"CB Johannes","year":"2010","unstructured":"Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010;11:1230\u20139.","journal-title":"J Pain."},{"key":"585_CR2","volume-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","author":"Committee on Advancing Pain Research, Care, and Education, Institute of Medicine, Board on Health Sciences Policy.","year":"2011","unstructured":"Committee on Advancing Pain Research, Care, and Education, Institute of Medicine, Board on Health Sciences Policy. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press; 2011."},{"key":"585_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpain.2018.07.006","volume":"20","author":"MH Pitcher","year":"2019","unstructured":"Pitcher MH, Korff MV, Bushnell MC, Porter L. Prevalence and profile of high-impact chronic pain in the United States. J Pain. 2019;20:146\u201360.","journal-title":"J Pain."},{"key":"585_CR4","volume-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Appendix C: The Economic Costs of Pain in the United States","author":"DJ Gaskin","year":"2017","unstructured":"Gaskin DJ, Richard P. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Appendix C: The Economic Costs of Pain in the United States. US: National Academies Press; 2017."},{"key":"585_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al. Regulation of \u00b5-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65:223\u201354.","journal-title":"Pharmacol Rev."},{"key":"585_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41467-017-00791-2","volume":"8","author":"SS Schattauer","year":"2017","unstructured":"Schattauer SS, Land BB, Reichard KL, Abraham AD, Burgeno LM, Kuhar JR, et al. Peroxiredoxin 6 mediates G\u03b1i protein-coupled receptor inactivation by cJun kinase. Nat Commun. 2017;8:743.","journal-title":"Nat Commun"},{"key":"585_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","volume":"38","author":"HL Fields","year":"2015","unstructured":"Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38:217\u201325.","journal-title":"Trends Neurosci."},{"key":"585_CR8","volume-title":"Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use","author":"JK Phillips","year":"2017","unstructured":"Phillips JK, Ford MA, Bonnie RJ, National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. US: National Academies Press; 2017."},{"key":"585_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/157015906778019527","volume":"4","author":"J Manzanares","year":"2006","unstructured":"Manzanares J, Julian M, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4:239\u201357.","journal-title":"Curr Neuropharmacol."},{"key":"585_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5055\/jom.2009.0034","volume":"5","author":"J Elikottil","year":"2009","unstructured":"Elikottil J, Gupta P, Gupta K. The analgesic potential of cannabinoids. J Opioid Manag. 2009;5:341\u201357.","journal-title":"J Opioid Manag"},{"key":"585_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","volume":"9","author":"S Vuc\u030ckovic\u0301","year":"2018","unstructured":"Vuc\u030ckovic\u0301 S, Srebro D, Vujovic\u0301 KS, Vuc\u030cetic\u0301 C\u030c, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259.","journal-title":"Front Pharmacol."},{"key":"585_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-017-0693-1","volume":"19","author":"EA Romero-Sandoval","year":"2018","unstructured":"Romero-Sandoval EA, Kolano AL, Alvarado-V\u00e1zquez PA. Cannabis and cannabinoids for chronic pain. Curr Rheumatol Rep. 2018;19:67.","journal-title":"Curr Rheumatol Rep"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ejp.1148","volume":"22","author":"J L\u00f6tsch","year":"2018","unstructured":"L\u00f6tsch J, Weyer-Menkhoff I, Tegeder I. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. Eur J Pain. 2018;22:471\u201384.","journal-title":"Eur J Pain"},{"key":"585_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuropharm.2016.05.021","volume":"109","author":"JD Nguyen","year":"2016","unstructured":"Nguyen JD, Aarde SM, Vandewater SA, Grant Y, Stouffer DG, Parsons LH, et al. Inhaled delivery of \u0394(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology. Neuropharmacology. 2016;109:112\u201320.","journal-title":"Neuropharmacology."},{"key":"585_CR15","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00213-018-4946-0","volume":"235","author":"M Javadi-Paydar","year":"2018","unstructured":"Javadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, et al. Effects of \u03949-THC and cannabidiol vapor inhalation in male and female rats. Psychopharmacology (Berl). 2018;235:2541\u201357.","journal-title":"Psychopharmacology (Berl)"},{"key":"585_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2018.04.018","volume":"137","author":"DG Barrus","year":"2018","unstructured":"Barrus DG, Lefever TW, Wiley JL. Evaluation of reinforcing and aversive effects of voluntary delta-9 tetrahydrocannabinol ingestion in rats. Neuropharmacology. 2018;137:133\u201340.","journal-title":"Neuropharmacology."},{"key":"585_CR17","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/acer.12404","volume":"38","author":"AG Schindler","year":"2014","unstructured":"Schindler AG, Tsutsui KT, Clark JJ. Chronic alcohol intake during adolescence, but not adulthood, promotes persistent deficits in risk-based decision-making. Alcohol Clin Exp Res. 2014;38:1622\u20139.","journal-title":"Alcohol Clin Exp Res"},{"key":"585_CR18","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.1017732108","volume":"108","author":"NA Nasrallah","year":"2011","unstructured":"Nasrallah NA, Clark JJ, Collins AL, Akers CA, Phillips PE, Bernstein IL. Risk preference following adolescent alcohol use is associated with corrupted encoding of costs but not rewards by mesolimbic dopamine. Proc Natl Acad Sci USA. 2011;108:5466\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR19","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41386-019-0387-7","volume":"44","author":"LC Kruse","year":"2019","unstructured":"Kruse LC, Cao JK, Viray K, Stella N, Clark JJ. Voluntary oral consumption of \u03949-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood. Neuropsychopharmacology. 2019;44:1406\u201314.","journal-title":"Neuropsychopharmacology."},{"key":"585_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","volume":"43","author":"Z Seltzer","year":"1990","unstructured":"Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205\u201318.","journal-title":"Pain"},{"key":"585_CR21","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1523\/JNEUROSCI.5552-03.2004","volume":"24","author":"M Xu","year":"2004","unstructured":"Xu M, Petraschka M, McLaughlin JP, Westenbroek R, Caron MG, Lefkowitz RJ, et al. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci. 2004;24:4576\u201384.","journal-title":"J Neurosci"},{"key":"585_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0166-2236(98)01302-2","volume":"22","author":"M Koltzenburg","year":"1999","unstructured":"Koltzenburg M, Wall PD, McMahon SB. Does the right side know what the left is doing? Trends Neurosci. 1999;22:122\u20137.","journal-title":"Trends Neurosci."},{"key":"585_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00115550-200805000-00004","volume":"33","author":"MJ Arguis","year":"2008","unstructured":"Arguis MJ, Perez J, Martinez G, Ubre M, Gomar C. Contralateral neuropathic pain following a surgical model of unilateral nerve injury in rats. Reg Anesth Pain Med. 2008;33:211\u20136.","journal-title":"Reg Anesth Pain Med"},{"key":"585_CR24","doi-asserted-by":"publisher","first-page":"e22093","DOI":"10.1371\/journal.pone.0022093","volume":"6","author":"H Sugimoto","year":"2011","unstructured":"Sugimoto H, Okabe S, Kato M, Koshida N, Shiroishi T, Mogi K, et al. A role for strain differences in waveforms of ultrasonic vocalizations during male-female interaction. PLoS ONE. 2011;6:e22093.","journal-title":"PLoS One"},{"key":"585_CR25","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1073\/pnas.1711351114","volume":"114","author":"JS Kaplan","year":"2017","unstructured":"Kaplan JS, Stella N, Catterall WA, Westenbroek RE. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci USA. 2017;114:11229\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2018.02.016","volume":"329","author":"H Li","year":"2018","unstructured":"Li H, Kong W, Chambers CR, Yu D, Ganea D, Tuma RF, et al. The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice. Cell Immunol. 2018;329:1\u20139.","journal-title":"Cell Immunol."},{"key":"585_CR27","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","volume":"50","author":"P Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay P, Rajesh M, Horva\u0301th B, Ba\u0301tkai S, Park O, Tanchian G, et al. Cannabidiol protects against hepatic ischemia\/reperfusion injury by attenuating inflammatory signaling and response, oxidative\/nitrative stress, and cell death. Free Radic Biol Med. 2011;50:1368\u201381.","journal-title":"Free Radic Biol Med"},{"key":"585_CR28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.20120242","volume":"209","author":"W Xiong","year":"2012","unstructured":"Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting \u03b13 glycine receptors. J Exp Med. 2012;209:1121\u201334.","journal-title":"J Exp Med"},{"key":"585_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/clpt.1980.181","volume":"28","author":"A Ohlsson","year":"1980","unstructured":"Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther. 1980;28:409\u201316.","journal-title":"Clin Pharmacol Ther"},{"key":"585_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.drugalcdep.2006.03.015","volume":"85","author":"JG Ramaekers","year":"2006","unstructured":"Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend. 2006;85:114\u201322.","journal-title":"Drug Alcohol Depend"},{"key":"585_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","volume":"163","author":"F Berrendero","year":"2002","unstructured":"Berrendero F, Maldonado R. Involement of the opioid system in the anxiolytic-like effects induced by Delta9-tetrahydrocannabinol. Psychopharmacology (Berl). 2002;163:111\u20137.","journal-title":"Psychopharmacology (Berl)"},{"key":"585_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnbeh.2019.00032","volume":"13","author":"CR Kasten","year":"2019","unstructured":"Kasten CR, Zhang Y, Boehm SL II. Acute cannaninoids produce robust anxiety-like and locomotor effects in mice, but long-term consequences are age- and sex- dependent. Front Behav Neurosci. 2019;13:32.","journal-title":"Front Behav Neurosci"},{"key":"585_CR33","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1097\/j.pain.0000000000001051","volume":"158","author":"SL Casey","year":"2017","unstructured":"Casey SL, Atwal N, Vaughan CW. Cannabis constituent synergy in a mouse neuropathic pain model. Pain. 2017;158:2452\u201360.","journal-title":"Pain."},{"key":"585_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000103923","volume":"80","author":"G Zernig","year":"2007","unstructured":"Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW, et al. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology. 2007;80:65\u2013119.","journal-title":"Pharmacology."},{"key":"585_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/npp.2014.188","volume":"40","author":"CL Wade","year":"2015","unstructured":"Wade CL, Vendruscolo LF, Schlosburg JE, Hernandez DO, Koob GF. Compulsive-like responding for opioid analgesics in rats with extended access. Neuropsychopharmacology. 2015;40:421\u20138.","journal-title":"Neuropsychopharmacology."},{"key":"585_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuropharm.2018.07.002","volume":"139","author":"Y Mulpuri","year":"2018","unstructured":"Mulpuri Y, Marty VN, Munier JJ, Mackie K, Schmidt BL, Seltzman HH, et al. Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. Neuropharmacology. 2018;139:85\u201397.","journal-title":"Neuropharmacology."},{"key":"585_CR37","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","volume":"96","author":"L Hanus","year":"1999","unstructured":"Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, et al. HU-308: A specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA. 1999;96:14228\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","volume":"3","author":"TP Malan Jr","year":"2003","unstructured":"Malan TP Jr, Ibrahim MM, Lai J, Vanderah TW, Makriyannis A, Porreca F. CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr Opin Pharmacol. 2003;3:62\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"585_CR39","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","volume":"96","author":"A Zimmer","year":"1999","unstructured":"Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA. 1999;96:5780\u201385.","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","volume":"11","author":"C Muller","year":"2019","unstructured":"Muller C, Morales P, Reggio PH. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2019;11:487.","journal-title":"Front Mol Neurosci"},{"key":"585_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-018-0395-2","volume":"11","author":"M Rodri\u0301guez-Mun\u0303oz","year":"2018","unstructured":"Rodri\u0301guez-Mun\u0303oz M, Onetti Y, Corte\u0301s-Montero E, Garzo\u0301n J, Sa\u0301nchez-Bla\u0301zquez P. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. Mol Brain. 2018;11:51.","journal-title":"Mol Brain"},{"key":"585_CR42","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3389\/fphar.2018.01496","volume":"9","author":"R Guerrero-Alba","year":"2019","unstructured":"Guerrero-Alba R, Barraga\u0301n-Iglesias P, Gonza\u0301lez-Herna\u0301ndez A, Valdez-Mora\u0301les EE, Granados-Soto V, Conde\u0301s-Lara M, et al. Some prospective alternatives for treating pain: the endocannabinoid system and its putative receptors GPR18 and GPR55. Front Pharmacol. 2019;9:1496.","journal-title":"Front Pharmacol."},{"key":"585_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nchembio.552","volume":"7","author":"W Xiong","year":"2011","unstructured":"Xiong W, Cheng K, Cui T, Godlewski G, Rice KC, Xu Y, et al. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Nat Chem Biol. 2011;7:296\u2013303.","journal-title":"Nat Chem Biol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0585-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0585-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0585-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:07:45Z","timestamp":1684602465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-019-0585-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1038\/s41386-019-0585-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/556373","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,7]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}